Which one of the following provides hemodynamic stability and prolongs survival in congestive heart failure?
**Question:** Which one of the following provides hemodynamic stability and prolongs survival in congestive heart failure?
A. Angiotensin-converting enzyme inhibitors (ACE inhibitors)
B. Beta-blockers
C. Calcium channel blockers
D. Diuretics
**Core Concept:**
Congestive heart failure (CHF) is a clinical syndrome characterized by the presence of structural and functional cardiac abnormalities that lead to a reduced cardiac output and/or increased vascular resistance. The management of CHF aims to improve cardiac output, reduce afterload, reduce preload, and reduce heart rate.
**Why the Correct Answer is Right:**
Among the options provided, ACE inhibitors (Option A) and beta-blockers (Option B) are the most appropriate medications for managing CHF.
**Why Each Wrong Option is Incorrect:**
Calcium channel blockers (Option C) are primarily used in hypertension and angina, not CHF. Diuretics (Option D) are primarily used to reduce congestion, but their long-term use can lead to electrolyte imbalances and worsening of renal function, making them less effective in the long term.
**Clinical Pearl / High-Yield Fact:**
In patients with CHF, ACE inhibitors and beta-blockers improve cardiac function, reduce symptoms, and prolong survival. ACE inhibitors inhibit the renin-angiotensin-aldosterone system (RAAS) and reduce afterload, while beta-blockers reduce heart rate and afterload. Both classes of drugs are essential components of the management of heart failure, particularly in patients with reduced ejection fraction (HFrEF).
**Correct Answer:**
Correct Answer: ACE inhibitors (Option A) and beta-blockers (Option B).
**Why ACE inhibitors and beta-blockers are right:**
1. ACE inhibitors (e.g., captopril, enalapril) target the renin-angiotensin-aldosterone system (RAAS), reducing angiotensin II, aldosterone, and vasopressin levels, which in turn decreases vascular resistance, improves cardiac output, and reduces neurohormonal activation.
2. Beta-blockers (e.g., metoprolol, bisoprolol) reduce cardiac workload by lowering heart rate and afterload, decreasing myocardial oxygen demand and improving ventricular function.
**Why other options are wrong:**
3. Calcium channel blockers (Option C) are primarily used in hypertension and angina, not CHF. They do not directly affect cardiac function but can lead to reflex tachycardia, worsening of renal function, and hypotension.
4. Diuretics (Option D) primarily reduce congestion but can lead to electrolyte imbalances (hypokalaemia and hyponatraemia), worsening renal function, and potential for worsening renal failure.